Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 10/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.35 |
| ▸ | RAB9A | P51151 | 9/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.35 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.33 |
| ▸ | RELA | Q04206 | 3/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25712542 | 0.86 | ALDH1A1 (0.34) | NPC1ALDH1A1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL20980466 | 0.84 | IRAK4 (0.32) | IRAK4NPC1ALDH1A1RAB9AKDM4E | |
| SCHEMBL20980471 | 0.79 | NPC1 (0.43) | NPC1ALDH1A1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL20980544 | 0.75 | WNK1 (0.34) | IRAK4NPC1RAB9ASMN1; SMN2LDHA | |
| SCHEMBL13834213 | 0.75 | LDHA (0.51) | IRAK4NPC1ALDH1A1RAB9AKDM4E | |
| SCHEMBL20980501 | 0.73 | IRAK4 (0.35) | IRAK4NPC1LDHAHSD17B1HSD17B2 | |
| SCHEMBL25712553 | 0.71 | GRM5 (0.32) | — | |
| SCHEMBL20980496 | 0.70 | RAB9A (0.39) | NPC1ALDH1A1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL20980504 | 0.70 | GRM4 (0.32) | NPC1ALDH1A1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL20980515 | 0.70 | GRM4 (0.32) | NPC1ALDH1A1RAB9AKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685756-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-27 | — | — | US | disclosed |
| US-11685756-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-27 | — | — | US | disclosed |
| US-11214587-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-01-04 | — | — | US | disclosed |
| US-20190135843-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685756-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OPRD1 | IRAK4 4374/4885NPC1 3147/4885ALDH1A1 2254/4885 |
| US-11214587-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OPRD1 | IRAK4 4374/4885NPC1 3147/4885ALDH1A1 2254/4885 |
| US-20190135843-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OPRD1 | IRAK4 4374/4885NPC1 3147/4885ALDH1A1 2254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.